Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28812060
Publication Date : 2017/08/16

Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma.


Oncolytic viruses (OVs) are emerging as powerful anti-cancer agents and are currently being tested for their safety and efficacy in patients. Reovirus (Reolysin), a naturally occurring non-pathogenic, double-stranded RNA virus, has natural oncolytic activity and is being tested in phase I-III clinical trials in a variety of tumor types. With its recent US Food and Drug Administration (FDA) orphan drug designation for several tumor types, Reolysin is a potential therapeutic agent for various cancers, including head and neck squamous cell carcinomas (HNSCCs), which have a 5-year survival of ∼55%. Histone deacetylase inhibitors (HDACis) comprise a structurally diverse class of compounds with targeted anti-cancer effects. The first FDA-approved HDACi, vorinostat (suberoylanilide hydroxamic acid [SAHA]), is currently being tested in patients with head and neck cancer. Recent findings indicate that HDAC inhibition in myeloma cells results in the upregulation of the Reolysin entry receptor, junctional adhesion molecule 1 (JAM-1), facilitating reovirus infection and tumor cell killing both in vitro and in vivo. In this study, we tested the anti-tumor efficacy of HDAC inhibitors AR-42 or SAHA in conjunction with Reolysin in HNSCCs. While HDAC inhibition increased JAM-1 and reovirus entry, the impact of this combination therapy was tested on the development of anti-tumor immune responses.

Authors : Jaime-Ramirez Alena C , Yu Jun-Ge , Caserta Enrico , Yoo Ji Young , Zhang Jianying , Lee Tae Jin , Hofmeister Craig , Lee John H , Kumar Bhavna , Pan Quintin , Kumar Pawan , Baiocchi Robert , Teknos Theodoros , Pichiorri Flavia , Kaur Balveen , Old Matthew ,

Related products :

Catalog number Product name Quantity
BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases_63 cores
BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases_63 cores; ihc Anti-H-CK confirmed
'CC34-11-001 Human Head and neck squamous cell carcinoma normal gingiva tongue tissue array tissues 8 x 9
1747 Head and neck squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing HN801
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases_72 cores, replaced by HN811
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases_72 cores, replaced by HN811; ihc Anti-H-CK confirmed
CC34-01-001 Human Head and neck squamous carcinoma tissue array (multi_sites, grade I ~ III) 7 x 9
CC34-01-001 Human Head and neck squamous carcinoma tissue array (multi_sites, grade I ~ III) 7 x 9
CC34-01-001 Human Head and neck squamous carcinoma tissue array (multi_sites, grade I ~ III) 7 x 9
'CC34-01-001 Human Head and neck squamous carcinoma tissue array (multi-sites, grade I ~ III) tissues 7 x 9
CC34-11-001 Human Head and neck squamous cell carcinoma_normal gingiva_tongue tissue array 8 x 9
CC34-11-001 Human Head and neck squamous cell carcinoma_normal gingiva_tongue tissue array 8 x 9
CC34-11-001 Human Head and neck squamous cell carcinoma_normal gingiva_tongue tissue array 8 x 9
'CC34-11-001 Human Head and neck squamous cell carcinoma_normal gingiva_tongue tissue array tissues 8 x 9
26-630 CTTN is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. CTTN is localized in the cytoplasm and in areas of the cell-substratum contacts. It has two roles (1) regulat 0.05 mg
Head&Neck - HND181 Head and neck disease tissue array, 18 cases of inflammatory and tumor tissues of the neck, oranasopharynx, larynx and salivary glands 2.5mm
Head&Neck - HNT961 Head and neck disease tissue array, 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynx, larynx and salivary glands 1.5 mm
HND181 Head and neck disease tissue array, 18 cases (2.5mm) Species Human Anatomic System Head and neck 2.5 mm
HNT1021 Head and neck tumor tissue array, 102 cases (1.5mm) Species Human Anatomic System Head and neck 1.5 mm
HNT961 Head and neck tumor tissue array, 48 cases, 96 samples (1.5mm) Species Human Anatomic System Head and neck 1.5 mm
IHDNK-N-1ml Head and Neck Carcinoma Plasma 1ml 1ml
IHDNK-N-Each Head and Neck Carcinoma Plasma Each
IHDNK-SER-1ml Head and Neck Carcinoma Serum 1ml 1ml
IHDNK-SER-Each Head and Neck Carcinoma Serum Each
IHDNK-TIS Carcinoma of Head and Neck Tissue Sample


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur